ICON PLC - ESG Rating & Company Profile powered by AI
The analysis of ICON PLC is prepared by All Street Sevva using proprietary NLP. This webpage is a free Sustainability analysis covering ICON PLC. The ESG rating includes 17 UN Sustainable Development Goals including: 'Gender Equality', 'Reduced Inequalities' and 'Life below Water'.
ICON PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 2.0, social score of 5.0 and governance score of 8.0.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
724 | Skye Bioscience Inc | 5.1 | High |
724 | Xbrane Biopharma AB | 5.1 | High |
744 | ICON PLC | 5.0 | High |
744 | CSL Ltd | 5.0 | High |
744 | CStone Pharmaceuticals | 5.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does ICON PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes ICON PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes ICON PLC report the average age of the workforce?
Sign up for free to unlockDoes ICON PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes ICON PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes ICON PLC disclose cybersecurity risks?
Sign up for free to unlockDoes ICON PLC offer flexible work?
Sign up for free to unlockDoes ICON PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes ICON PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes ICON PLC conduct supply chain audits?
Sign up for free to unlockDoes ICON PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes ICON PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes ICON PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes ICON PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes ICON PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes ICON PLC disclose water use targets?
Sign up for free to unlockDoes ICON PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid ICON PLC have a product recall in the last two years?
Sign up for free to unlockDoes ICON PLC disclose incidents of discrimination?
Sign up for free to unlockDoes ICON PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas ICON PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes ICON PLC disclose parental leave metrics?
Sign up for free to unlockDoes ICON PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes ICON PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes ICON PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes ICON PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes ICON PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes ICON PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs ICON PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes ICON PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes ICON PLC disclose its waste policy?
Sign up for free to unlockDoes ICON PLC report according to TCFD requirements?
Sign up for free to unlockDoes ICON PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes ICON PLC disclose energy use targets?
Sign up for free to unlockDoes ICON PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes ICON PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for ICON PLC
These potential risks are based on the size, segment and geographies of the company.
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.